Who is ineligible for warfarin in atrial fibrillation?
Verheugt
Freek W A
FW
Department of Cardiology, Onze Lieve Vrouwe Gasthuis, 1091 AC Amsterdam, Netherlands. f.w.a.verheugt@olvg.nl
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000517:prevention & control*; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D020521:Stroke / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin